Home/Filings/4/0001562180-19-003677
4//SEC Filing

Ross Leonard S 4

Accession 0001562180-19-003677

CIK 0001314102other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 5:04 PM ET

Size

9.1 KB

Accession

0001562180-19-003677

Insider Transaction Report

Form 4
Period: 2019-06-27
Ross Leonard S
Corporate Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2019-06-27+6,66792,005 total
  • Tax Payment

    Common Stock

    2019-06-27$1.65/sh1,961$3,23690,044 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-06-276,6676,667 total
    Exercise: $0.00Common Stock (6,667 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
  • [F3]On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001458753

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:04 PM ET
Size
9.1 KB